AbbVie Move Against Data Transparency | Reuters Events | Pharma
Taking Citrate-Free Humira: What Patients Need to Know
Trial Of Usability in Clinical settings of HUMIRA autoinjector versus... | Download Scientific Diagram
HUMIRA (adalimumab) Dermatology Healthcare Professional Site
Safety | Crohn's Disease (CD) | HUMIRA® (adalimumab)
HUMIRA (adalimumab) Dermatology Healthcare Professional Site
VARSITY Ulcerative Colitis Clinical Trial | Entyvio® (vedolizumab)
BioSpace Feature: A Look at Miracle Drug Humira's Journey to Proven Efficacy | BioSpace
Ulcerative Colitis Remission & HUMIRA® Results (adalimumab)
![PDF] Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial](https://d3i71xaburhd42.cloudfront.net/1f3ea24e842b7750dfbe6b098b7b1b52e074980f/5-Figure1-1.png "PDF] Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial")
PDF] Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial
HUMIRA® (adalimumab) for Rheumatoid Arthritis (RA)
Adalimumab trials show low rate of IBD adverse events
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis | SpringerLink
Humira, INN - adalimumab
Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed | Annals of the Rheumatic Diseases
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis | NEJM
Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty‐six‐week phase 3 open‐label study - Yamasaki - 2020 - The Journal of Dermatology - Wiley Online Library
Frontiers | Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial | Medicine
VARSITY Ulcerative Colitis Clinical Trial | Entyvio® (vedolizumab)
Adalimumab - Wikipedia
Crohn's Remission and Results With HUMIRA® (adalimumab)
HUMIRA (adalimumab) Dermatology Healthcare Professional Site
Long-Term Safety of Adalimumab (HUMIRA) in Adult Patients from Global Clinical Trials across Multiple Indications: An Updated Analysis in 29,987 Patients Representing 56,951 Patient-Years - ACR Meeting Abstracts
Humira Biosimilars Clinical Trial Insight - Research and Markets
